As of February 2025 Recursion Pharmaceuticals has a market cap of NZ$6.31 Billion. This makes Recursion Pharmaceuticals the world's 3231th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$6.31 B | 23.33% |
2024 | NZ$5.11 B | 52.11% |
2023 | NZ$3.36 B | 46.22% |
2022 | NZ$2.30 B | -45.69% |
2021 | NZ$4.23 B |
On Feb 21st, 2025 the market cap of Recursion Pharmaceuticals was reported to be: